Impact of genetic variation in CYP2C19, CYP2D6, and CYP3A4 on oxycodone and its metabolites in a large database of clinical urine drug tests

The Pharmacogenomics Journal, Published online: 03 September 2021; doi:10.1038/s41397-021-00253-5Impact of genetic variation in CYP2C19, CYP2D6, and CYP3A4 on oxycodone and its metabolites in a large database of clinical urine drug tests

Source: The Pharmacogenomics Journal - September 3, 2021 Category: Drugs & Pharmacology Authors: Guang-dan Zhu Penn Whitley Leah LaRue Brandon Adkins Eric Dawson Angela Huskey Edmund V. Capparelli Andria L. Del Tredici Source Type: research